A detailed history of New England Professional Planning Group Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, New England Professional Planning Group Inc. holds 1,250 shares of ABBV stock, worth $246,025. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,250
Previous 1,254 0.32%
Holding current value
$246,025
Previous $228,000 6.14%
% of portfolio
0.11%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$154.79 - $180.76 $619 - $723
-4 Reduced 0.32%
1,250 $214,000
Q1 2024

Apr 12, 2024

BUY
$159.82 - $182.1 $200,414 - $228,353
1,254 New
1,254 $228,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $348B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track New England Professional Planning Group Inc. Portfolio

Follow New England Professional Planning Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Professional Planning Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Professional Planning Group Inc. with notifications on news.